For example, altered expression of citrate synthase (CS), aconitase (ACO2) and malate dehydrogenase (MDH2) has been reported to contribute to cancer-specific features, such as glycolysis addiction, resistance to chemotherapy and increased lipid biosynthesis [2–4]. The gene discussed is CS; the disease is cancer.